| NAME |
APOMORPHINE HCL 10MG/ML INJ,SOLN,2ML |
| VA GENERIC NAME |
APOMORPHINE |
| DOSAGE FORM |
INJ,SOLN |
| FORMULARY DESIGNATOR |
PA-F |
| FORMULARY DESIGNATOR TEXT |
Restricted to neurology for treatment of acute hypomobility episode of advanced Parkinson's disease.
|
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY INDICATOR |
YES |
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
10 |
| INACTIVATION DATE |
2007-09-18 00:00:00 |
| UNITS |
MG/ML |
| NATIONAL FORMULARY NAME |
APOMORPHINE INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
APOMORPHINE 10MG/ML SOLN INJ 2ML |
| VA PRODUCT IDENTIFIER |
A1230 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
AMP |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4017106 |
| EFFECTIVE DATE/TIME |
-
- 2005-03-10 00:00:00
- STATUS: ACTIVE
-
- 2007-09-18 00:00:00
- STATUS: INACTIVE
|
